Chemical Market Consolidation, 2019-2023: Who will not survive?
- Will the industry consolidate, decentralize, or undergo a bimodal transformation?
- How will the current trends affect the major market segments?
- Which companies will enter the market and which will not survive?
The report provides:
- Specific business, new product development and marketing strategies.
- Strengths and weaknesses.
- Anticipated acquisitions, joint ventures and divestitures.
- Major promotional strategies.
- Distribution approaches.
- Product service and support.
- Internally developed and acquired chemical and related capabilities.
- Proprietary Technologies and patent litigations.
1. BASF
2. DOW
3. DUPONT
4. EXXONMOBIL
5. MITSUBISHI
6. SHELL
THE REPORT PROVIDES:
Specific business, new product development and marketing strategies
Strengths and weaknesses
Anticipated acquisitions, joint ventures and divestitures
Major promotional strategies
Distribution approaches
Product service and support
Internally developed and acquired chemical and related capabilities
Proprietary technologies and patent litigations
2. DOW
3. DUPONT
4. EXXONMOBIL
5. MITSUBISHI
6. SHELL
THE REPORT PROVIDES:
Specific business, new product development and marketing strategies
Strengths and weaknesses
Anticipated acquisitions, joint ventures and divestitures
Major promotional strategies
Distribution approaches
Product service and support
Internally developed and acquired chemical and related capabilities
Proprietary technologies and patent litigations
More Publications
2016 Orthopedics Market Consolidation: Who will not survive?
US$ 3,880.00
October 2015
136 pages
Flavor and Fragrance Market Consolidation: Who will not survive?
US$ 2,450.00
November 2019
150 pages
Chemical Market Consolidation: Who will not survive?
US$ 2,450.00
November 2019
121 pages
Animal Health Market Consolidation, 2019-2023: Who will not survive?
US$ 2,450.00
July 2019
110 pages
2015-2019 Orthopedics Market Consolidation: Who will not survive?
US$ 3,880.00
July 2015
136 pages
